Everything you need to know about importing investigational products into Venezuela — from INHRR authorization and customs clearance to cold chain logistics and common pitfalls.
July 31, 2026
13
min read
By
bioaccess® Editorial Team
investigational product import Venezuela
clinical trial logistics Venezuela
**Key Takeaways**
- • INHRR authorization required for all investigational product imports
- • Timeline: import authorization and customs timing varies by study; we confirm it per protocol
- • Start early: Begin IP import logistics at least 8 weeks before site activation
- • Cold chain: Temperature monitoring required throughout the import chain
- • Labeling: Must include "For Clinical Trial Use Only" in Spanish
**The short answer**
Importing investigational products into Venezuela requires INHRR import authorization plus customs clearance; timing varies by study (we confirm it per protocol). Sponsors should begin import logistics at least 8 weeks before site activation, with temperature monitoring throughout the chain and “For Clinical Trial Use Only” labeling in Spanish. The import window runs in parallel with site activation (phase 5 of the study-specific timeline), so early planning compresses overall startup.
What does importing investigational products into Venezuela require?
Importing investigational products (IP) into Venezuela for clinical trial use requires INHRR authorization, proper customs documentation, and careful logistics planning. Whether importing investigational drugs, biologics, or medical devices for early feasibility studies, sponsors must navigate a defined regulatory pathway.
bioaccess® manages the complete IP import process for sponsors, from INHRR authorization to final delivery at the clinical site, ensuring compliance with Venezuelan regulations and GCP requirements.
How does INHRR import authorization work?
Before any investigational product can enter Venezuela, sponsors must obtain an import authorization from INHRR. This authorization is typically issued as part of, or following, the clinical trial approval process.
- Application submitted to INHRR's import division
- Must reference the approved clinical trial protocol number
- Specifies the product, quantity, dosage forms, and destination site
- GMP certificate of the manufacturing facility required
- Certificate of Analysis for each batch being imported
- Authorization typically valid for the duration of the trial
Which documents are required for IP import?
- INHRR import authorization letter
- Commercial invoice describing the IP (marked 'No Commercial Value')
- Packing list with batch numbers and quantities
- Certificate of Analysis for each batch
- GMP certificate of the manufacturer
- Temperature monitoring documentation (for cold chain products)
- Airway bill or bill of lading
- Customs broker authorization letter from the sponsor/CRO
How does customs clearance work?
Customs clearance for investigational products in Venezuela involves coordination with a licensed customs broker experienced in pharmaceutical/medical imports.
| Step | Activity | Duration |
|---|---|---|
| 1 | Submit customs documentation | Day 0 |
| 2 | Customs inspection and verification | 3-5 days |
| 3 | INHRR authorization verification by customs | 2-3 days |
| 4 | Duty/tax assessment (usually exempt for clinical trial IP) | 1-2 days |
| 5 | Release and transfer to site | 1-2 days |
What are the cold chain requirements?
Products requiring temperature-controlled storage (2-8°C, -20°C, or -80°C) require:
- Validated shipping containers with temperature data loggers
- Continuous temperature monitoring from origin to destination
- Qualified cold chain logistics provider with Venezuelan operations
- Temperature excursion procedures documented in advance
- Site pharmacy with verified cold storage capabilities
- Documentation of temperature maintenance for GCP compliance
What should sponsors know about medical device IP?
Investigational medical devices have additional import considerations:
- Device specifications and technical documentation
- Sterilization certificates (for sterile devices)
- Shelf-life and storage condition requirements
- Device accountability logs and tracking procedures
- Special handling requirements for sensitive equipment
- Compliance with international packaging and labeling standards
An investigational-product import authorization is not a license to sell. Commercial medical-device registration with SACS is a separate workstream.
What pitfalls cause delays, and how can sponsors avoid them?
- Insufficient lead time — start 8+ weeks before needed at site
- Missing 'For Clinical Trial Use Only' labeling in Spanish
- Expired or missing GMP certificates causing customs holds
- Inadequate temperature monitoring documentation
- Incorrect customs tariff codes leading to unexpected duties
- Not engaging a customs broker experienced with clinical trial IP
- Failing to coordinate with site pharmacy for receiving procedures
How does bioaccess® manage IP logistics in Venezuela?
bioaccess® provides end-to-end investigational product import management for Venezuela:
- INHRR import authorization application and follow-up
- Customs broker coordination and documentation preparation
- Cold chain logistics with validated providers
- Temperature monitoring and excursion management
- Site pharmacy coordination for receiving and storage
- Drug accountability and IP tracking throughout the trial
**Need help importing IP to Venezuela?**
Contact bioaccess® for complete IP logistics management for your clinical trial in Venezuela.
Frequently asked questions
Planning your next step in Venezuela?
Explore clinical-trial planning for protocol-specific research questions, or medical-device registration and market access for SACS documentation and local registration arrangements. These are separate regulatory workstreams.
Get your FIH roadmap for Venezuela
From IP import to patient enrollment — bioaccess® handles every detail.